Not a clinical ranking. These are discovery prompts for common-use or high-attention classes. Diognosis separates authority, literature, linked, and modeled provenance; none is medical advice or clinical validation.
Scale rationale uses public U.S. prescription-use signals from CDC/NCHS and MEPS-derived ClinCalc DrugStats; examples are chosen because they are useful Diognosis discovery prompts, not because they are the most dangerous combinations.
Statins and Lipid Medicines
Common chronic therapy where CYP3A inhibition, transporter blockade, fibrates, boosters, and oncology drugs can raise muscle-toxicity risk.
Blood Pressure and Heart Failure
Common medicines where the biggest misses are often potassium, renal function, bradycardia, hypotension, or timing rules rather than CYP alone.
Anticoagulants and Antiplatelets
High-scale and high-review burden: bleeding, INR shifts, transporter induction, antiplatelet activation, NSAIDs, SSRIs, antibiotics, and supplements converge.
Diabetes and Weight-Loss Medicines
Common and growing exposure. Useful for metformin renal/exposure checks, insulin hypoglycemia masking, GLP-1/GIP insulin changes, and anticoagulant monitoring.
Pain, Inflammation, and Migraine
High-scale because OTC and prescription pain medicines commonly overlap with anticoagulants, antidepressants, lithium, methotrexate, kidneys, and CYP2D6 activation.
Psychiatry, Neurology, Sleep, and OTC Sedating Medicines
Captures serotonin toxicity, CYP2D6/CYP2C19 phenotype shifts, anticholinergic/sedation burden, seizure threshold, sodium, and bradycardia in older-adult patterns.
Antibiotics, Antifungals, and Antivirals
Common short courses can collide with chronic medicines through CYP3A, CYP2C9, P-gp, OATP, QT, and absorption.
Acid Suppression, GI, Minerals, and Binding Interactions
Useful for non-CYP misses: pH-dependent absorption, chelation, binding, dose separation, thyroid monitoring, and antiviral/antibiotic treatment failure.
Contraception, Hormones, and Reproductive Health
High-scale counseling category where induction, lamotrigine level shifts, perioperative drugs, and pregnancy-context flags matter.
QT Risk, Antiarrhythmics, and Rate Control
Narrow-index and electrophysiology checks: QT stacking, renal cation transport, beta-blockade, CYP2D6 phenotype, and bradycardia.
Oncology, Immunology, and Transplant
Specialist, not scale-first, but important because many examples are active-metabolite, genotype, transporter, or narrow-index cases that ordinary parent-drug checks miss.